Co-Authors
This is a "connection" page, showing publications co-authored by Pierluigi Viale and Carlo Tascini.
Connection Strength
0.460
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.234
-
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med. 2021 Aug 08; 10(16).
Score: 0.060
-
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther. 2021 Dec; 10(4):1837-1885.
Score: 0.060
-
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul; 26(7):880-894.
Score: 0.055
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.052